By Professor Glenda Halliday

Journal articles

Kwok JB; Hallupp M; Loy CT; Chan DK; Woo J; Mellick GD; Buchanan D; Silburn PA; Halliday GM; Schofield PR, 2005, 'GSK3B polymorphisms alter transcription and splicing in Parkinson`s disease', Annals of Neurology, 58, pp. 829 - 839

Halliday GM; Lepar G; Harding AJ; Kwok JBJ, 2005, 'Inheritance of dementia with Lewy bodies: comment and review of the literature', Current Trends in Neurology, 1, pp. 51 - 66

Broe M; Shepherd CE; Mann DM; Milward EA; Gai WP; Kettle E; Halliday GM, 2005, 'Insoluble alpha-synuclein in Alzheimer's disease without Lewy body formation', Neurotoxicity Research, 7, pp. 69 - 76

Fedorow HS; Tribl F; Halliday GM; Gerlach M; Riederer P; Double KL, 2005, 'Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson`s disease', Progress in Neurobiology, 75, pp. 109 - 124

Shepherd CE; Gregory GC; Vickers J; Halliday GM, 2005, 'Novel 'inflammatory plaque' pathology in presenelin-1 Alzheimer's disease', Neuropathology and Applied Neurobiology, 31, pp. 503 - 511

Huang Y; Garrick R; Cook R; O Sullivan DJ; Morris JG; Halliday GM, 2005, 'Pallidal stimulation reduces treatment-induced dyskinesias in `minimal-change` multiple system atrophy', Movement Disorders, 20, pp. 1042 - 1047

Graham A; Davies R; Xuereb J; Halliday GM; Kril J; Creasey H; Graham K; Hodges JR, 2005, 'Pathologically proven frontotemporal dementia presenting with severe amnesia', Brain, 128, pp. 597 - 605

Raftery MJ; Campbell R; Glaros EN; Rye K; Halliday GM; Jessup W; Garner B, 2005, 'Phosphorylation of apolipoprotein-E at an atypical protein kinase CK2 PSD/E site in vitro.', Biochemistry, 44, pp. 7346 - 7353

Halliday GM; Song YC; Lepar GS; Brooks WS; Kwok JB; Kersaitis C; Gregory GC; Shepherd CE; Rahimi F; Schofield PR; Kril J, 2005, 'Pick bodies in a family with presenilin-1 Alzheimer's disease', Annals of Neurology, 57, pp. 139 - 143

Schofield EC; Caine D; Kril J; Cordato N; Halliday GM, 2005, 'Staging disease severity in movement disorder tauopathies: Brainatrophy separates progressive supranuclear palsy from corticobasaldegeneration', Movement Disorders, 20, pp. 34 - 39

Halliday GM, 2005, 'The emergence of proto-objects in complex visual hallucinations', Behavioral and Brain Sciences, 28, pp. 767 - 768

Davies R; Hodges JR; Kril J; Patterson K; Halliday GM; Xuereb J, 2005, 'The pathological basis of semantic dementia', Brain, 128, pp. 1984 - 1995

Gregory GC; Halliday GM, 2005, 'What is the dominant A beta species in human brain tissue? A review', Neurotoxicity Research, 7, pp. 29 - 41

Barnetson RSC; Satchell A; Zhuang L; Slade HB; Halliday GM, 2004, 'Imiquimod induced regression of clinically diagnosed superficial basal cell carcinoma is associated with early infiltration by CD4 T cells and dendritic cells', CLINICAL AND EXPERIMENTAL DERMATOLOGY, 29, pp. 639 - 643, http://dx.doi.org/10.1111/j.1365-2230.2004.01614.x

Duma S; Chalkley S; Halliday G; Broe GA, 2004, 'The role of the pre-SMA in age related gait disorder', AUSTRALASIAN JOURNAL ON AGEING, 23, pp. A49 - A50, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208445000159&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hersey P; Menzies SW; Halliday GM; Nguyen T; Farrelly ML; DeSilva C; Lett M, 2004, 'Phase I/II study of treatment with dendritic cell vaccines in patients with disseminated melanoma', Cancer Immunology, Immunotherapy, 53, pp. 125 - 134, http://dx.doi.org/10.1007/s00262-003-0429-0

Meredith G; Halliday GM; Totterdell S, 2004, 'A critical review of the development and importance of proteinaceous aggregates in animal models of Parkinson`s disease: new insights into Lewy body formation', Parkinsonism and Related Disorders, 10, pp. 191 - 202

Aarsland D; Ballard C; Halliday GM, 2004, 'Are Parkinson`s disease with dementia and dementia with Lewy bodies the same entity?', Journal of Geriatric Psychiatry and Neurology, 17, pp. 137 - 145

Broe M; Kril J; Halliday GM, 2004, 'Astrocytic degeneration relates to the severity of disease infrontotemporal dementia', Brain, 127, pp. 2214 - 2220

Hodges JR; Davies R; Xuereb J; Casey B; Broe M; Bak T; Kril J; Halliday GM, 2004, 'Clinicopathological correlates in frontotemporal dementia', Annals of Neurology, 56, pp. 399 - 406

Kril J; Halliday GM, 2004, 'Clinicopathological staging of frontotemporal dementia severity: correlation with regional atrophy', Dementia and Geriatric Cognitive Disorders, 17, pp. 311 - 315

Mckeith IG; Mintzer J; Aarsland D; Burn D; Chiu H; Cohen-Mansfield J; Dickson D; Dubois B; Dua JE; Feldman H; Gauthier S; Halliday GM; Lawlor B; Lippa C; Lopez O; Machado JC; O Brien J; Playfer J; Reid WG, 2004, 'Dementia with Lewy bodies', Lancet Neurology, 3, pp. 19 - 28

Stanford PM; Brooks WS; Teber E; Hallupp M; McLean CA; Halliday GM; Martins RN; Kwok JB; Schofield PR, 2004, 'Frequency of tau mutations in familial and sporadic frontotemporal dementia and other tauopathies', Journal of Neurology, 251, pp. 1098 - 1104

Huang Y; Cheung L; Rowe DB; Halliday GM, 2004, 'Genetic contributions to Parkinson`s disease', Brain Research Reviews, 46, pp. 44 - 70

Brooks WS; Kwok JB; Halliday GM; Godbolt AK; Rossor MN; Creasey H; Jones A; Schofield PR, 2004, 'Hemorrhage is uncommon in new Alzheimer family with Flemish amyloid precursor protein mutation', Neurology, 63, pp. 1613 - 1617

Harding AJ; Das A; Kril J; Brooks WS; Duffy DL; Halliday GM, 2004, 'Identification of families with cortical Lewy body disease', American Journal of Medical Genetics Part A, 128B, pp. 118 - 122

Henderson JM; Rodriguez M; O Sullivan DJ; Pell MF; Fung VS; Benabid AL; Halliday GM, 2004, 'Partial lesion of thalamic ventral intermediate nucleus after chronic high-frequency stimulation', Movement Disorders, 19, pp. 709 - 711

Shepherd CE; Gregory GC; Vickers J; Brooks WS; Kwok J; Schofield PR; Kril J; Halliday GM, 2004, 'Positional effects of presenilin-1 mutations on tau phosphorylation in cortical plaques', Neurobiology of Disease, 15, pp. 115 - 119

Kersaitis C; Halliday GM; Kril J, 2004, 'Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without Pick bodies', ACTA Neuropathologica, 108, pp. 515 - 523

Kril J; Hodges JR; Halliday GM, 2004, 'Relationship between hippocampal volume and CA1 neuron loss in brains of humans with and without Alzheimer's disease', Neuroscience Letters, 361, pp. 9 - 12

KRIL J, 2004, 'Relationship between hippocampal volume and CA1 neuron loss in brains of humans with and without Alzheimer's disease*1', Neuroscience Letters, 361, pp. 9 - 12, http://dx.doi.org/10.1016/s0304-3940(04)00134-x

Piguet O; Brooks WS; Halliday GM; Schofield PR; Stanford PM; Kwok JB; Spillantini M; Yancopoulou D; Nestor PJ; Broe G; Hodges JR, 2004, 'Similar early clinical presentations in familial and non-familial frontotemporal dementia', Journal of Neurosurgery, 75, pp. 1743 - 1745

Poon TSC; Kuchel JM; Badruddin A; Halliday GM; Barnetson RS; Iwaki H; Hatao M, 2003, 'Objective measurement of minimal erythema and melanogenic doses using natural and solar-simulated light', PHOTOCHEMISTRY AND PHOTOBIOLOGY, 78, pp. 331 - 336, http://dx.doi.org/10.1562/0031-8655(2003)078<0331:OMOMEA>2.0.CO;2

Byrne SN; Halliday GM, 2003, 'Phagocytosis by dendritic cells rather than MHC IIhigh macrophages is associated with skin tumour regression', INTERNATIONAL JOURNAL OF CANCER, 106, pp. 736 - 744, http://dx.doi.org/10.1002/ijc.11274

Kuchel JM; Barnetson RS; Halliday GM, 2003, 'Nitric oxide appears to be a mediator of solar-simulated ultraviolet radiation-induced immunosuppression in humans', JOURNAL OF INVESTIGATIVE DERMATOLOGY, 121, pp. 587 - 593, http://dx.doi.org/10.1046/j.1523-1747.2003.12415.x

Poon TSC; Barnetson RS; Halliday GM, 2003, 'Prevention of immunosuppression by sunscreens in humans is unrelated to protection from erythema and dependent on protection from ultraviolet A in the face of constant ultraviolet B protection', JOURNAL OF INVESTIGATIVE DERMATOLOGY, 121, pp. 184 - 190, http://dx.doi.org/10.1046/j.1523-1747.2003.12317.x

Byrne SN; Halliday GM, 2003, 'High levels of Fas ligand and MHC class II in the absence of CD80 or CD86 expression and a decreased CD4(+) T cell Infiltration, enables murine skin tumours to progress', CANCER IMMUNOLOGY IMMUNOTHERAPY, 52, pp. 396 - 402, http://dx.doi.org/10.1007/s00262-003-0380-0

Agar NS; Halliday GM; Barnetson RS; Jones AM, 2003, 'A novel technique for the examination of skin biopsies by laser capture microdissection', JOURNAL OF CUTANEOUS PATHOLOGY, 30, pp. 265 - 270, http://dx.doi.org/10.1046/j.0303-6987.2003.052.x

Bennett HP; Piguet O; Grayson DA; Creasey H; Waite LM; Broe T; Halliday GM, 2003, 'A 6-year study of cognition and spatial function in the demented and non-demented elderly: The Sydney Older Persons Study', Dementia and Geriatric Cognitive Disorders, 16, pp. 181 - 186

Caramins M; Halliday GM; McCusker E; Trent RJ, 2003, 'Genetically confirmed clinical Huntingdon`s disease with no observable cell loss', Journal of Neurology Neurosurgery and Psychiatry, 74, pp. 968 - 970

Halliday GM; Double KL; Macdonald V; Kril J, 2003, 'Identifying severely atrophic cortical subregions in Alzheimer's disease', Neurobiology of Aging, 24, pp. 797 - 806

Double KL; Rowe DB; Hayes M; Chan DK; Blackie J; Corbett AJ; Joffe R; Fung VS; Morris JG; Halliday GM, 2003, 'Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test', Archives of Neurology, 60, pp. 545 - 549

Stanford PM; Shepherd CE; Halliday GM; Brooks WS; Schofield PR, 2003, 'Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia', Brain, 126, pp. 814 - 826

Henderson JM; Lu Y; Wang SS; Cartwright HR; Halliday GM, 2003, 'Olfactory deficits and sleep disturbance in Parkinson`s disease: a case-control survey', Journal of Neurology Neurosurgery and Psychiatry, 74, pp. 956 - 958

Kwok JB; Halliday GM; Brooks WS; Dolios G; Laudon H; Murayama O; Hallupp M; Vickers J; Wang R; Naslund J; Takashima A; Gandy SE; Badenhop RF; Schofield PR, 2003, 'Presenilin-1 mutation L271V results in altered exon 8 splicing and Alzheimer's disease with non-cored plaques and no neuritic dystrophy', The Journal of Biological Chemistry, 278, pp. 6748 - 6754

Henderson JM; Watson S; Halliday GM; Heinemann T; Gerlach M, 2003, 'Relationships between various behavioural abnormalities and nigrostriatal dopamine depletion in the unilateral 6-OHDA-lesioned rat', Behavioural Brain Research, 139, pp. 105 - 113

Schofield E; Kersaitis C; Shepherd CE; Kril J; Halliday GM, 2003, 'Severity of gliosis in Pick`s disease and frontotemporal lobar degeneration: tau-positive glia differentiate these disorders', Brain, 126, pp. 827 - 840

Broe M; Hodges JR; Schofield E; Shepherd CE; Kril J; Halliday GM, 2003, 'Staging disease severity in pathologically confirmed cases of frontotemporal dementia', Neurology, 60, pp. 1005 - 1011

Hodges JR; Davies RI; Xuereb J; Kril J; Halliday GM, 2003, 'Survival in frontotemporal dementia', Neurology, 61, pp. 349 - 354

Double KL; Halliday GM; Henderson J; Griffiths F; Heinemann T; Riederer P; Gerlach M, 2003, 'The dopamine receptor agonist lisuride attenuates iron-mediated dopaminergic neurodegeneration', Experimental Neurology, 184, pp. 530 - 535

Back to profile page